Acadia Healthcare Company, Inc.

As of June 30, 2026, Acadia Healthcare Company, Inc. carries a market capitalization of 2.31B, placing it among publicly traded companies globally. Its enterprise value stands at 4.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Acadia Healthcare Company, Inc.'s next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Acadia Healthcare Company, Inc. has 90.87M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.78, and the price-to-book ratio stands at 1.33.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.56 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 4.59B versus a market cap of 2.31B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Acadia Healthcare Company, Inc. maintains a current ratio of 1.57, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 117.04, indicating elevated leverage, while an interest coverage ratio of -4.96 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Acadia Healthcare Company, Inc. posted a negative return on equity (ROE) of -44.54, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -19.00, reflecting losses generated across the asset base. The company generates approximately 117,322.36 in revenue per employee across its workforce of 25,125.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 20.01 indicates how many times Acadia Healthcare Company, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Acadia Healthcare Company, Inc. recorded 22.55M in income tax expense. The company reported a pretax loss of -959.71M and -985.80M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 6, 2026, Acadia Healthcare Company, Inc.'s stock has gained approximately 14.04% over the past 52 weeks. The 50-day moving average sits at 25.15, while the 200-day moving average is 21.15.

Over the twelve months ended June 30, 2026, Acadia Healthcare Company, Inc. generated 2.95B in revenue and converted that into -985.80M in net income, yielding earnings per share of -10.82. EBITDA reached -655.87M, while operating income came in at 296.53M.

As of June 30, 2026, Acadia Healthcare Company, Inc. holds 149.93M in cash and equivalents against 2.25B in total debt, resulting in a net debt position of 1.96B. Total book value stands at 1.73B, with working capital of 269.34M providing operational flexibility.

Acadia Healthcare Company, Inc. produced 184.26M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Acadia Healthcare Company, Inc. posted a gross margin of 96.41, reflecting its pricing power and cost economics. The operating margin of 10.06 and net profit margin of -33.44 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 7.99, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -5.48, meaning Acadia Healthcare Company, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Acadia Healthcare Company, Inc.'s most recent stock split took place on November 1, 2011 with a 4:1 split ratio.

As of June 30, 2026, Acadia Healthcare Company, Inc. has an Altman Z-Score of 1.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.